---
figid: PMC12170998__jcav16p2595g003
figtitle: Molecular pathways related to EGFR-TKI resistance
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12170998
filename: jcav16p2595g003.jpg
figlink: /pmc/articles/PMC12170998/figure/F3/
number: F3
caption: Schematic diagram of the molecular pathways related to EGFR-TKI resistance.
  EGFR kinase domain mutations and the upregulation or activation of other RTKs (such
  as AXL, MET, HER2 and IGF-1R which can cross the suppressed EGFR signaling pathway
  and activate downstream pathways) lead to resistance to EGFR-TKIs
papertitle: Development of Traditional Chinese Medicine in combination with EGFR Inhibitors
  against Cancer
reftext: Xiao Chen, et al. J Cancer. 2025;16(8).
year: '2025'
doi: 10.7150/jca.109420
journal_title: Journal of Cancer
journal_nlm_ta: J Cancer
publisher_name: Ivyspring International Publisher
keywords: EGFR | EGFR-TKI | EGFR monoclonal antibody | traditional Chinese medicine
  monomers | traditional Chinese medicine | cancer
automl_pathway: 0.9596601
figid_alias: PMC12170998__F3
figtype: Figure
redirect_from: /figures/PMC12170998__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12170998__jcav16p2595g003.html
  '@type': Dataset
  description: Schematic diagram of the molecular pathways related to EGFR-TKI resistance.
    EGFR kinase domain mutations and the upregulation or activation of other RTKs
    (such as AXL, MET, HER2 and IGF-1R which can cross the suppressed EGFR signaling
    pathway and activate downstream pathways) lead to resistance to EGFR-TKIs
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AXL
  - EGFR
  - IGF1R
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - PTEN
  - IGF1
  - ERBB2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - MET
  - RAS
  - MEK
---
